Möchten Sie immer auf dem neuesten Stand bleiben?

Completed randomization in REMAIN-1 Pivotal Cohort; topline 6-Month data expected in early Q4 2026 Received favorable FDA feedback on De Novo classification request; De Novo submission expected in...

UBS will make Human Interest available as a recordkeeping solution on its platform for financial advisors in the US

Hyderabad, March 24, 2026 (GLOBE NEWSWIRE) -- According to a research report by Mordor Intelligence, the protein hydrolysate market size was valued at USD 3.8 billion in 2025 and is estimated to...

Miata Intersects 96 m of 1.41 g/t gold in Near-Surface Gold System at Big Berg, Delivering Best Intercept to Date at the Sela Creek Gold Project, Suriname

Launched VIZZ® (aceclidine ophthalmic solution) 1.44% for the treatment of presbyopia in October 2025 and generated net product revenues of $1.6 million in the first quarter of launch On pace for...

Addgene and Plasmidsaurus announce that they have entered into a strategic partnership to scale sequencing for leading plasmid repository.

Tigris publication confirms positive results for primary and key secondary endpoints with 95.3% and 99.4% probability of benefit for PMX at 28-day and 90-day mortality After adjusting for baseline...

~ Delivered Record Annual Revenue with Full-Year Net PEDMARK® Product Sales of $44.6 Million, Representing 50% Year-Over-Year Growth, and Q4 2025 Net Product Sales of $13.8 Million, Representing 75%...

Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained disease remission through Week 36 compared with placebo ...

Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid Approval in moderate-to-severe patients was based on pivotal study results...